Please use this identifier to cite or link to this item:
|Title:||Osteo-maturation of adipose-derived stem cells required the combined action of vitamin D3, β-glycerophosphate, and ascorbic acid||Authors:||Gupta, A.
|Keywords:||Adipose-derived stem cells
|Issue Date:||12-Oct-2007||Citation:||Gupta, A., Leong, D.T., Bai, H.F., Singh, S.B., Lim, T.-C., Hutmacher, D.W. (2007-10-12). Osteo-maturation of adipose-derived stem cells required the combined action of vitamin D3, β-glycerophosphate, and ascorbic acid. Biochemical and Biophysical Research Communications 362 (1) : 17-24. ScholarBank@NUS Repository. https://doi.org/10.1016/j.bbrc.2007.07.112||Abstract:||This study investigated the effects of various components [vitamin D3 (VD3), β-glycerophosphate (BGP), and ascorbic acid (AA)] on the potential of human adipose-derived progenitor cells (ADPCs) to transdifferentiate into osteoblast-like cells. ADPCs were induced under four different supplement groups: (1) VD3 + BGP + AA, (2) VD3 alone, (3) BGP + AA, and (4) no VD3, BGP or AA. Mineralization studies and presence of bone matrix-related proteins by immunostaining showed that the Group 1 ADPCs showed their ability to undergo osteoblastic differentiation. Further evaluation was made by estimation of levels of RUNX-2 and TAZ genes. Group 1 ADPCs showed the consistent expression of RUNX-2 and TAZ levels over the study period of 28 days. The study showed good correlation among various parameters evaluated to conclude that ADPCs could be an alternative source for generating osteoblast-like cells. © 2007 Elsevier Inc. All rights reserved.||Source Title:||Biochemical and Biophysical Research Communications||URI:||http://scholarbank.nus.edu.sg/handle/10635/67208||ISSN:||0006291X||DOI:||10.1016/j.bbrc.2007.07.112|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Aug 15, 2019
WEB OF SCIENCETM
checked on Aug 8, 2019
checked on Aug 18, 2019
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.